GMRS · GMR Solutions Inc.
Price & Indicators
The closing range uses available history since May 13, 2026; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 13, 2026TL;DR. GMR Solutions reported Q2 2026 revenue up 3.3% to $1.49B with adjusted EBITDA down 11.8% to $284.5M (largely due to a $74M prior-year NSA estimate comp and ~$16M ACA exchange payer-mix headwind), a swing to a $28.3M net loss driven by $142.3M of IPO-related expenses, and reaffirmed full-year guidance while flagging continued Iran-conflict fuel/cost pressure.
- + Q2 revenue grew 3.3% YoY to $1,490.3M with continued momentum in emergent services
- + Liquidity strengthened with $420M cash and ~$696M undrawn ABL capacity following IPO capital actions and credit rating upgrade
- + Net leverage already at 3.5x (down from 4.3x) with line of sight to below 3.3x by year-end and 3.0x by end of 2027
- + 911 Nurse Navigation scaled to 29 communities / 19.7M covered lives with calls up 50% YoY and four more implementations planned
- − Adjusted EBITDA fell 11.8% YoY to $284.5M as margin pressure from ACA exchange subsidy expiration and higher costs weighed on results
- − Net loss of $28.3M in Q2 vs. $80.8M net income prior year, driven by $142.3M of IPO-related stock comp and professional fees
- − Total operating expense rose 19.4% YoY to $1.43B, with employee wages up 24.5% and fuel/maintenance up 21.1% on Iran-conflict and aircraft maintenance timing
- − CapEx and aircraft financing stepped up to 6.3% of revenue vs. 4.5% prior year due to pull-forward of purchases
- − Year-over-year No Surprises Act/IDR revenue estimate tailwind was $74M lower, creating a meaningful comparability drag
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GMRS
this stock
GMR Solutions Inc.
|
$673.65M | — | — | — | 6.0% |
|
HCA
HCA Healthcare, Inc.
|
$93.44B | -8.6% | +7.1% | 14.5 | 2.8% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.33B | -8.7% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.06B | +32.7% | +0.9% | 10.1 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.01B | +14.7% | +10.5% | 19.8 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GMRS | -4.7% | -8.5% | — | +5.2% | — |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -3.6% | -6.7% | — | +5.6% | — |